ArticleScientometrics2020
Comparing like with like: China ranks first in SCI-indexed research articles since 2018.
Article in Scientometrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Transitioning from invasive to liquid biopsy techniques: a bibliometric analysis and prospective insights on biomarkers in lupus nephritis.Frontiers in medicine · 2026Pooled it
- Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics.Frontiers in oncology · 2024Pooled it
- Improving English proficiency for scientific communication by non-fluent speakers.Nature reviews. Cardiology · 2025Article
- Vegetable Fibers in Cement Composites: A Bibliometric Analysis, Current Status, and Future Outlooks.Materials (Basel, Switzerland) · 2025Review
- How does equity restriction affect innovation quality? Evidence from listed manufacturing companies in China.PloS one · 2023Article
- Applications of artificial intelligence in the field of air pollution: A bibliometric analysis.Frontiers in public health · 2022Article
- The Pandemic Year 2020: World Map of Coronavirus Research.Journal of medical Internet research · 2021Article
- The Bibliometric Literature on Scopus and WoS: The Medicine and Environmental Sciences Categories as Case of Study.International journal of environmental research and public health · 2021Article
- Positive Organizational Psychology: A Bibliometric Review and Science Mapping Analysis.International journal of environmental research and public health · 2021Review
- The Prediction of Infectious Diseases: A Bibliometric Analysis.International journal of environmental research and public health · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
China's rising in scientific research output is impressive. The academic community is curious about the time when the cross-over in the number of annual scientific publication production between China and the USA can happen. By using Web of Science Core Collection's Science Citation Index Expanded database, this study finds that China still ranks the second in the production of SCI-indexed publications in 2019 but may leapfrog the USA to be the first in 2020 or 2021, if all document types are considered. Comparatively, China has already overtaken the USA and been the largest SCI-indexed original research article producer since 2018. However, China still lags behind the USA regarding the number of review paper production. In general, quantitative advantage does not equal quality or impact advantage. We think that the USA will continue to be the global scientific leader for a long time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.